Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Roche Products (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 105mg/0.7 ml

Dosage Form : INJ

Dosage Strength : 105mg

Packaging : 0.7X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 150mg/1 ml

Dosage Form : INJ

Dosage Strength : 150mg

Packaging : 1X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 60mg/0.4 ml

Dosage Form : INJ

Dosage Strength : 60mg

Packaging : 0.4X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Emicizumab

Brand Name : Hemlibra 30mg/1 ml

Dosage Form : INJ

Dosage Strength : 30mg

Packaging : 1X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank